Imetelstat Sodium

4 trials Orphan designation

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

0 Recruiting

3 Completed trials

2 Sponsors

13 Countries

Phase III

Phase II/III

Phase II

Phase III: 1 Phase II/III: 1 Phase II: 2

Indications tested

Myelofibrosis 1

Sponsors using this IMP

Gcp-Service International West GmbH 2 Geron Corp. 2

All trials

4 total

A phase II study evaluating the efficacy and safety of IMetelstat in Patients with HR myElodysplastic SyndromeS or AML failing HMA-based the… Not authorised

2022-500721-32-00 Phase II 2 countries Gcp-Service International West GmbH
A phase II study evaluating the efficacy and safety of IMetelstat in Patients with HR myElodysplastic SyndromeS or AML failing HMA-based the… Ended

2022-500721-32-01 Phase II 2 countries Gcp-Service International West GmbH
A study comparing current available therapies with imetelstat for the treatment of intermediate-2 or high-risk MF who are not responding to … Ended

2023-509120-17-00 Phase III 11 countries Geron Corp.
Study to Evaluate Imetelstat (GRN163L) in Subjects with IPSS Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) Ended

2024-511348-25-00 Phase II/III 8 countries Geron Corp.

Showing 1–4 of 4 trials

← All drugs A–Z